Britain's Competition and Markets Authority is conducting a formal Phase 1 investigation into AkzoNobel and Axalta's proposed $25 billion merger to determine whether the combination would substantially lessen competition in the UK, with a statutory decision deadline of November 11.
- The $25 billion merger between AkzoNobel and Axalta combines two major coating systems companies with roughly $17 billion in combined 2024 revenue.
- The UK Competition and Markets Authority (CMA) has until November 11 to complete its Phase 1 investigation, though this deadline can be extended in limited circumstances.
- The combined company would be domiciled in the Netherlands with dual headquarters in Amsterdam and Philadelphia, targeting $600 million in run-rate synergies.
- Both companies' shareholders approved the all-stock merger on August 5, 2026, with expected closing in late 2026 or early 2027 pending regulatory approvals.
- This is the companies' second merger attempt, following failed merger-of-equals talks in 2017 after AkzoNobel rejected multiple takeover offers from PPG Industries.
Britain's Competition and Markets Authority is launching an investigation into the proposed merger between AkzoNobel and Axalta Coating Systems.
The regulator has until Nov. 11 to decide whether the combination, valued at roughly $25 billion, threatens to substantially lessen competition in the UK.
The CMA said opening the formal inquiry "does not itself represent a finding that the transaction would reduce competition."
The review follows an earlier, informal step: the agency invited public comment on the deal for a 15-day window between April 16 and May 1, describing it at the time as "a preliminary step ahead of its Phase 1 investigation."
The Nov. 11 deadline is a statutory Phase 1 limit, not necessarily a finish line. The CMA website notes that "the statutory deadline can be extended in certain limited circumstances," while also saying it "will seek to determine its investigation as quickly as possible."
Combined with its statement that opening the inquiry carries no presumption about the outcome, the regulator has left itself room to either clear the deal, resolve concerns short of a deeper probe, or extend its review — each of which lands on a different timeline for the companies.
AkzoNobel and Axalta have themselves flagged that outcome as one of the last open variables before closing. In announcing the merger, the companies said they expect to close "in late 2026 to early 2027, subject to approval by shareholders of both AkzoNobel and Axalta, the receipt of requisite regulatory approvals, authorization for the combined company's shares to be listed on NYSE, payment of the special dividend by AkzoNobel, completion of AkzoNobel's works council consultation requirements and the satisfaction of other customary closing conditions."
Elsewhere in the same release, the companies warned that a risk to completing the deal is if "a regulatory approval that may be required for the proposed transaction is delayed, is not obtained or is obtained subject to conditions that are not anticipated."
AkzoNobel and Axalta announced their all-stock "merger of equals" in November 2025. Under the terms, Axalta shareholders receive 0.6539 AkzoNobel shares for each share held, leaving AkzoNobel shareholders with about 55 percent of the combined company and Axalta shareholders with about 45 percent. The deal values the combined business at close to $25 billion in enterprise value, with roughly $17 billion in combined 2024 revenue. Shareholders of both companies approved the transaction on Aug. 5, 2026.
The combined company would be domiciled in the Netherlands with dual headquarters in Amsterdam and Philadelphia, initially listed on both Euronext Amsterdam and the New York Stock Exchange before consolidating onto the NYSE alone.
Leadership would draw from both sides: Axalta's Rakesh Sachdev as chair, AkzoNobel's Ben Noteboom as vice-chair, AkzoNobel CEO Greg Poux-Guillaume (pictured) as chief executive, and Axalta CEO Chris Villavarayan as deputy CEO, with Axalta's Carl Anderson as CFO.
The companies have targeted roughly $600 million in run-rate synergies and expect to close in late 2026 or early 2027, pending regulatory approval.
"This merger will allow us to accelerate our growth ambitions by bringing together highly complementary technologies, expertise and passionate people to unlock our full combined potential," Poux-Guillaume said when the deal was announced. Noteboom called it "a compelling opportunity" that would "create a world leader in coatings."
Villavarayan said the combination gives Axalta "a sharper competitive edge and new avenues and opportunities for growth," while Sachdev said the Axalta board was "confident that this combination with AkzoNobel will create significant value for our shareholders."
The current deal is not the companies' first attempt at combining. AkzoNobel and Axalta held merger-of-equals talks in 2017 that collapsed that November, weeks after AkzoNobel had rebuffed a series of takeover approaches from PPG Industries worth up to $28.8 billion.
